Our firm represented Kanso Diagnostics in its successful closing of its seed funding round, joining the Incentive incubator, backed by Peregrine, the Israel Innovation Authority, Shaare Zedek Hospital and industry giants like Beckton Dickinson and Bristol Myers Squibb.
This funding accelerates Kanso’s mission to transform the molecular diagnostics industry, empowering the company to develop modern diagnostic solutions that are accessible, versatile, and user-friendly, truly enabling diagnostics anytime, anywhere and by anyone.